Cocaine, reward, movement and monoamine transporters (original) (raw)
Johanson CE, Fischman MW . The pharmacology of cocaine related to its abuse Pharmacol Rev 1989 41: 3–52 CASPubMed Google Scholar
Gawin FH . Cocaine addiction: psychology and neurophysiology Science 1991 251: 1580–1586 CASPubMed Google Scholar
Satel SL, Southwick SM, Gawin FH . Clinical features of cocaine induced paranoia NIDA Res Monogr 1991 105: 371 Google Scholar
Kuhar MJ, Ritz MC, Boja JW . The dopamine hypothesis of the reinforcing properties of cocaine Trends Neurosci 1991 14: 299–302 CASPubMed Google Scholar
Spealman RD, Madras BK, Bergman J . Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior J Pharmacol Exp Ther 1989 251: 142–149 CASPubMed Google Scholar
Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ . Cocaine receptors on dopamine transporters are related to self-administration of cocaine Science 1987 237: 1219–1223 CASPubMed Google Scholar
Kuhar MJ, Ritz MC, Sharkey J . Cocaine receptors on dopamine transporters mediate cocaine-reinforced behavior NIDA Res Monogr 1988 88: 14–22 CASPubMed Google Scholar
Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ . Cocaine self-administration appears to be mediated by dopamine uptake inhibition Prog Neuropsychopharmacol Biol Psychiatry 1988 12: 233–239 CASPubMed Google Scholar
Roberts DC, Corcoran ME, Fibiger HC . On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine Pharmacol Biochem Behav 1977 6: 615–620 CASPubMed Google Scholar
Roberts DC, Koob GF, Klonoff P, Fibiger HC . Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens Pharmacol Biochem Behav 1980 12: 781–787 CASPubMed Google Scholar
Roberts DC, Koob GF . Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats Pharmacol Biochem Behav 1982 17: 901–904 CASPubMed Google Scholar
Lyness WH, Friedle NM, Moore KE . Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration Pharmacol Biochem Behav 1979 11: 553–556 CASPubMed Google Scholar
Edmonds DE, Gallistel CR . Reward versus performance in self-stimulation: electrode-specific effects of alpha-methyl-p-tyrosine on reward in the rat J Comp Physiol Psychol 1977 91: 962–974 CASPubMed Google Scholar
Gallistel CR, Boytim M, Gomita Y, Klebanoff L . Does pimozide block the reinforcing effect of brain stimulation? Pharmacol Biochem Behav 1982 17: 769–781 CASPubMed Google Scholar
Wasserman EM, Gomita Y, Gallistel CR . Pimozide blocks reinforcement but not priming from MFB stimulation in the rat Pharmacol Biochem Behav 1982 17: 783–787 CASPubMed Google Scholar
Gomita Y, Gallistel CR . Effects of reinforcement-blocking doses of pimozide on neural systems driven by rewarding stimulation of the MFB: a 14C-2-deoxyglucose analysis Pharmacol Biochem Behav 1982 17: 841–845 CASPubMed Google Scholar
Gallistel CR, Karras D . Pimozide and amphetamine have opposing effects on the reward summation function Pharmacol Biochem Behav 1984 20: 73–77 CASPubMed Google Scholar
Gunne LM, Anggard E, Jonsson LE . Clinical trials with amphetamine-blocking drugs Psychiatr Neurol Neurochir 1972 75: 225–226 CASPubMed Google Scholar
Wilson MC, Schuster CR . The effects of chlorpromazine on psychomotor stimulant self-administration in the rhesus monkey Psychopharmacologia 1972 26: 115–126 CASPubMed Google Scholar
Yokel RA, Wise RA . Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats Psychopharmacol (Berl) 1976 48: 311–318 CAS Google Scholar
Yokel RA, Wise RA . Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward Science 1975 187: 547–549 CASPubMed Google Scholar
De Wit H, Wise RA . Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine Can J Psychol 1977 31: 195–203 CASPubMed Google Scholar
Shimada S, Kitayama S, Lin CL, Patel A, Nanthakumar E, Gregor P et al. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA Science 1991 254: 576–578 CASPubMed Google Scholar
Kilty JE, Lorang D, Amara SG . Cloning and expression of a cocaine-sensitive rat dopamine transporter Science 1991 254: 578–579 CASPubMed Google Scholar
Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T et al. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter Mol Pharmacol 1992 42: 383–390 CASPubMed Google Scholar
Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR Genomics 1992 14: 1104–1106 CASPubMed Google Scholar
Vandenbergh DJ, Persico AM, Uhl GR . A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs Brain Res Mol Brain Res 1992 15: 161–166 CASPubMed Google Scholar
Lossie AC, Vandenbergh DJ, Uhl GR, Camper SA . Localization of the dopamine transporter gene, Datl, on mouse chromosome 13 Mamm Genome 1994 5: 117–118 CASPubMed Google Scholar
Vandenbergh DJ, Thompson MD, Cook EH, Bendahhou E, Nguyen T, Krasowski MD et al. Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations Mol Psychiatry 2000 5: 283–292 CASPubMed Google Scholar
Donovan DM, Vandenbergh DJ, Perry MP, Bird GS, Ingersoll R, Nanthakumar E et al. Human and mouse dopamine transporter genes: conservation of 5′-flanking sequence elements and gene structures Brain Res Mol Brain Res 1995 30: 327–335 CASPubMed Google Scholar
Persico AM, Macciardi F . Genotypic association between dopamine transporter gene polymorphisms and schizophrenia Am J Med Genet 1997 74: 53–57 CASPubMed Google Scholar
Persico AM, Catalano M . Lack of association between dopamine transporter gene polymorphisms and delusional disorder Am J Med Genet 1998 81: 163–165 CASPubMed Google Scholar
Grunhage F, Schulze TG, Muller DJ, Lanczik M, Franzek E, Albus M et al. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1) Mol Psychiatry 2000 5: 275–282 CASPubMed Google Scholar
Hamilton SP, Haghighi F, Heiman GA, Klein DF, Hodge SE, Fyer AJ et al. Investigation of dopamine receptor (DRD4) and dopamine transporter (DAT) polymorphisms for genetic linkage or association to panic disorder Am J Med Genet 2000 96: 324–330 CASPubMed Google Scholar
Kim JW, Kim DH, Kim SH, Cha JK . Association of the dopamine transporter gene with Parkinson's disease in Korean patients J Korean Med Sci 2000 15: 449–451 CASPubMedPubMed Central Google Scholar
Martinez D, Gelernter J, Abi-Dargham A, van Dyck CH, Kegeles L, Innis RB et al. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans Neuropsychopharmacology 2001 24: 553–560 CASPubMed Google Scholar
Samochowiec J, Rybakowski F, Czerski P, Zakrzewska M, Stepié N et al. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationship to temperamental dimensions measured by the temperament and character inventory in healthy volunteers Neuropsychobiology 2001 43: 248–253 CASPubMed Google Scholar
Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG et al. Genotype influences in vivo dopamine transporter availability in human striatum Neuropsychopharmacology 2000 22: 133–139 CASPubMed Google Scholar
Kang AM, Palmatier MA, Kidd KK . Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3) Biol Psychiatry 1999 46: 151–60 CASPubMed Google Scholar
Jonsson EG, Nothen MM, Gustavsson JP, Neidt H, Bunzel R, Propping P et al. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers Psychiatry Res 1998 79: 1–9 CASPubMed Google Scholar
Leighton PW, Le Couteur DG, Pang CC, McCann SJ, Chan D, Law LK et al. The dopamine transporter gene and Parkinson's disease in a Chinese population Neurology 1997 49: 1577–1579 CASPubMed Google Scholar
Dobashi I, Inada T, Hadano K . Alcoholism and gene polymorphisms related to central dopaminergic transmission in the Japanese population Psychiatr Genet 1997 7: 87–91 CASPubMed Google Scholar
Plante-Bordeneuve V, Taussig D, Thomas F, Said G, Wood NW, Marsden CD et al. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele Neurology 1997 48: 1589–1593 CASPubMed Google Scholar
Fujiwara Y, Yamaguchi K, Tanaka Y, Tomita H, Shiro Y, Kashihara K et al. Polymorphism of dopamine receptors and transporter genes in neuropsychiatric diseases Eur Neurol 1997 38 (Suppl 1): 6–10 Google Scholar
Inada T, Sugita T, Dobashi I, Inagaki A, Kitao Y, Matsuda G et al. Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode Am J Med Genet 1996 67: 406–408 CASPubMed Google Scholar
Gomez-Casero E, de Castro Perez I, Saiz-Ruiz J, Llinares C, Fernandez-Piqueras J . No association between particular DRD3 and DAT gene polymorphisms and manic-depressive illness in a Spanish sample Psychiatr Genet 1996 6: 209–212 CASPubMed Google Scholar
Bodeau-Pean S, Laurent C, Campion D, Jay M, Thibaut F, Dollfus S et al. No evidence for linkage or association between the dopamine transporter gene and schizophrenia in a French population Psychiatry Res 1995 59: 1–6 CASPubMed Google Scholar
Daniels J, Williams J, Asherson P, McGuffin P, Owen M . No association between schizophrenia and polymorphisms within the genes for debrisoquine 4-hydroxylase (CYP2D6) and the dopamine transporter (DAT) Am J Med Genet 1995 60: 85–87 CASPubMed Google Scholar
Gelernter J, Kranzler HR, Satel SL, Rao PA . Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia Neuropsychopharmacology 1994 11: 195–200 CASPubMed Google Scholar
Persico AM, Vandenbergh DJ, Smith SS, Uhl GR . Dopamine transporter gene polymorphisms are not associated with polysubstance abuse Biol Psychiatry 1993 34: 265–267 CASPubMed Google Scholar
Persico AM, Wang ZW, Black DW, Andreasen NC, Uhl GR, Crowe RR . Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disorders Am J Psychiatry 1995 152: 134–136 CASPubMed Google Scholar
Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S et al. A genetic association for cigarette smoking behavior Health Psychol 1999 18: 7–13 CASPubMed Google Scholar
Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B et al. Evidence suggesting the role of specific genetic factors in cigarette smoking Health Psychol 1999 18: 14–20 CASPubMed Google Scholar
Miller GM, Yatin SM, De La Garza R 2nd, Goulet M, Madras BK . Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity(1) Brain Res Mol Brain Res 2001 87: 124–143 CASPubMed Google Scholar
Miller GM, De La Garza RD 2nd, Novak MA, Madras BK . Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders Mol Psychiatry 2001 6: 50–58 CASPubMed Google Scholar
Giros B, Jaber M, Jones SR, Wightman RM, Caron MG . Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 1996 379: 606–612 CASPubMed Google Scholar
Donovan DM, Miner LL, Perry MP, Revay RS, Sharpe LG, Przedborski S et al. Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression Brain Res Mol Brain Res 1999 73: 37–49 CASPubMed Google Scholar
Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R et al. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice Proc Natl Acad Sci USA 1998 95: 7699–7704 CASPubMedPubMed Central Google Scholar
Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice Proc Natl Acad Sci USA 2001 98: 1982–1987 CASPubMedPubMed Central Google Scholar
Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB et al. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference Proc Natl Acad Sci USA 2001 98: 5300–5305 CASPubMedPubMed Central Google Scholar
Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW et al. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants Nat Neurosci 2000 3: 465–471 CASPubMed Google Scholar
Buck K, Lischka T, Dorow J, Crabbe J . Mapping quantitative trait loci that regulate sensitivity and tolerance to quinpirole, a dopamine mimetic selective for D(2)/D(3) receptors Am J Med Genet 2000 96: 696–705 CASPubMed Google Scholar
Barr CL, Xu C, Kroft J, Feng Y, Wigg K, Zai G et al. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder Biol Psychiatry 2001 49: 333–339 CASPubMed Google Scholar
Daly G, Hawi Z, Fitzgerald M, Gill M . Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children Mol Psychiatry 1999 4: 192–196 CASPubMed Google Scholar
Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL et al. Association and linkage of the dopamine transporter gene and attention- deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity Am J Hum Genet 1998 63: 1767–1776 CASPubMedPubMed Central Google Scholar
Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M . Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism Mol Psychiatry 1997 2: 311–313 CASPubMed Google Scholar
Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al. Association of attention-deficit disorder and the dopamine transporter gene Am J Hum Genet 1995 56: 993–998 CASPubMedPubMed Central Google Scholar
Swanson J, Posner M, Fusella J, Wasdell M, Sommer T, Fan J . Genes and attention deficit hyperactivity disorder Curr Psychiatry Rep 2001 3: 92–100 CASPubMed Google Scholar
Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B et al. Cocaine self-administration in dopamine-transporter knockout mice [published erratum appears in Nat Neurosci 1998; 1: 330] Nat Neurosci 1998 1: 132–137 CASPubMed Google Scholar
Hall FS, Sora I, Li XF, Lesch KP, Murphy DL, Xu F et al. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions J Neurosci (submitted)
Rothman RB, Glowa JR . A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909 Mol Neurobiol 1995 11: 1–19 CASPubMed Google Scholar
Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G . Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene J Neurosci 2001 21: RC141 PubMedPubMed Central Google Scholar
Yen TT, Fuller RW . Preclinical pharmacology of fluoxetine, a serotonergic drug for weight loss Am J Clin Nutr 1992 55(1 Suppl): 177S–180S Google Scholar
Tella SR . Effects of monoamine reuptake inhibitors on cocaine self-administration in rats Pharmacol Biochem Behav 1995 51: 687–692 CASPubMed Google Scholar
Zawertailo LA, Busto U, Kaplan HL, Sellers EM . Comparative abuse liability of sertraline, alprazolam, and dextroamphetamine in humans J Clin Psychopharmacol 1995 15: 117–124 CASPubMed Google Scholar
Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D, Korszun A . Replacement medication for cocaine dependence: methylphenidate J Clin Psychopharmacol 1997 17: 485–488 CASPubMed Google Scholar
Lobl JK, Carbone LD . Emergency management of cocaine intoxication. Counteracting the effects of today's ‘favorite drug’ Postgrad Med 1992 91: 161–162 165–166 CASPubMed Google Scholar
Ettenberg A, Raven MA, Danluck DA, Necessary BD . Evidence for opponent-process actions of intravenous cocaine Pharmacol Biochem Behav 1999 64: 507–512 CASPubMed Google Scholar
DeVries AC, Pert A . Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by corticotropin-releasing factor Psychopharmacol (Berl) 1998 137: 333–340 CAS Google Scholar
DeVries AC, Taymans SE, Sundstrom JM, Pert A . Conditioned release of corticosterone by contextual stimuli associated with cocaine is mediated by corticotropin-releasing factor Brain Res 1998 786: 39–46 CASPubMed Google Scholar
Pickworth WB, Klein SA, Bunker EB, Henningfield JE . Assessment of mazindol for abuse liability NIDA Res Monogr 1991 105: 443 Google Scholar
Chait LD, Uhlenhuth EH, Johanson CE . Reinforcing and subjective effects of several anorectics in normal human volunteers J Pharmacol Exp Ther 1987 242: 777–783 CASPubMed Google Scholar
Wilson MC, Schuster CR . Mazindol self-administration in the rhesus monkey Pharmacol Biochem Behav 1976 4: 207–210 CASPubMed Google Scholar
Bosse R, Fumagalli F, Jaber M, Giros B, Gainetdinov RR, Wetsel WC et al. Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter Neuron 1997 19: 127–138 CASPubMed Google Scholar
Gainetdinov RR, Jones SR, Caron MG . Functional hyperdopaminergia in dopamine transporter knock-out mice Biol Psychiatry 1999 46: 303–311 CASPubMed Google Scholar
Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine (‘Ecstasy’) in serotonin transporter-deficient mice Mol Pharmacol 1998 53: 649–655 CASPubMed Google Scholar
Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG . Profound neuronal plasticity in response to inactivation of the dopamine transporter Proc Natl Acad Sci USA 1998 95: 4029–4034 CASPubMedPubMed Central Google Scholar
Benoit-Marand M, Jaber M, Gonon F . Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences Eur J Neurosci 2000 12: 2985–2992 CASPubMed Google Scholar
Jaber M, Dumartin B, Sagne C, Haycock JW, Roubert C, Giros B et al. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter Eur J Neurosci 1999 11: 3499–3511 CASPubMed Google Scholar
Fauchey V, Jaber M, Caron MG, Bloch B, Le Moine C . Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter Eur J Neurosci 2000 12: 19–26 CASPubMed Google Scholar
Liu QR, Hall FS, Sora I, Uhl GR . Unpublished data
Stamford JA, Kruk ZL, Millar J . Striatal dopamine terminals release serotonin after 5-HTP pretreatment: in vivo voltammetric data Brain Res 1990 515: 173–180 CASPubMed Google Scholar
Vanhatalo S, Soinila S . Release of false transmitter serotonin from the dopaminergic nerve terminals of the rat pituitary intermediate lobe Neurosci Res 1995 22: 367–374 CASPubMed Google Scholar
Bonhomme N, De Deurwaerdere P, Le Moal M, Spampinato U . Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat Neuropharmacology 1995 34: 269–279 CASPubMed Google Scholar
Boulenguez P, Rawlins JN, Chauveau J, Joseph MH, Mitchell SN, Gray JA . Modulation of dopamine release in the nucleus accumbens by 5-HT1B agonists: involvement of the hippocampo-accumbens pathway Neuropharmacology 1996 35: 1521–1529 CASPubMed Google Scholar
Lejeune F, Millan MJ . Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635- reversible actions of the highly selective ligands, flesinoxan and S 15535 Synapse 1998 30: 172–180 CASPubMed Google Scholar
West AR, Galloway MP . Regulation of serotonin-facilitated dopamine release in vivo: the role of protein kinase A activating transduction mechanisms Synapse 1996 23: 20–27 CASPubMed Google Scholar
Berretta N, Bernardi G, Mercuri NB . Alpha(1)-adrenoceptor-mediated excitation of substantia nigra pars reticulata neurons Neuroscience 2000 98: 599–604 CASPubMed Google Scholar
Bowers BJ, Henry MB, Thielen RJ, McBride WJ . Serotonin 5-HT(2) receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat J Neurochem 2000 75: 1625–1633 CASPubMed Google Scholar
Di Giovanni G, Di Matteo V, Di Mascio M, Esposito E . Preferential modulation of mesolimbic vs nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study Synapse 2000 35: 53–61 CASPubMed Google Scholar
Di Matteo V, Di Mascio M, Di Giovanni G, Esposito E . Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin2C receptors Psychopharmacol (Berl) 2000 150: 45–51 CAS Google Scholar
Shi WX, Pun CL, Zhang XX, Jones MD, Bunney BS . Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors J Neurosci 2000 20: 3504–3511 CASPubMedPubMed Central Google Scholar